Femasys to Participate in 78th Annual American Society for Reproductive Medicine (ASRM) Scientific Congress
ATLANTA, Oct. 14, 2022 (GLOBE NEWSWIRE) — Femasys Inc. (NASDAQ:FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, today announced that the Company’s management team will be attending the 78th Annual American Society for Reproductive Medicine (ASRM) Scientific Congress to be held in Anaheim, California from October 22-26, 2022.
Related news for (FEMY)
- Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
- Don’t Miss Out: MoBot’s Latest Stock Updates 09/08/25 01:00 PM
- 24/7 Market News Snapshot 08 September, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)
- 24/7 Market News Snapshot 08 September, 2025 – Femasys Inc. Common Stock (NASDAQ:FEMY)
- Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control